On November 30, 2017 Johnson & Johnson (NYSE: JNJ) reported that it will participate in the BMO Capital Markets Healthcare Conference on Thursday, Dec. 14, at the Westin Grand Central, in New York, NY (Press release, Johnson & Johnson, NOV 30, 2017, View Source [SID1234522331]). Sandi Peterson, Executive Vice President, Group Worldwide Chairman will represent the Company in a session scheduled at 8:30 a.m. (Eastern Time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

View original content with multimedia:View Source;johnson-to-participate-in-the-bmo-capital-markets-healthcare-conference-300564699.html